Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Pediatr Radiol ; 39(3): 260-4, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19104796

ABSTRACT

Cerebral perfusion-weighted imaging (PWI) in neonates is known to be technically difficult and there are very few published studies on its use in preterm infants. In this paper, we describe one convenient method to perform PWI in neonates, a method only recently used in newborns. A device was used to manually inject gadolinium contrast material intravenously in an easy, quick and reproducible way. We studied 28 newborn infants, with various gestational ages and weights, including both normal infants and those suffering from different brain pathologies. A signal intensity-time curve was obtained for each infant, allowing us to build perfusion maps. This technique offered a fast and easy method to manually inject a bolus gadolinium contrast material, which is essential in performing PWI in neonates. Cerebral PWI is technically feasible and reproducible in neonates of various gestational age and with various pathologies.


Subject(s)
Cerebrovascular Disorders/diagnosis , Contrast Media/administration & dosage , Gadolinium DTPA/administration & dosage , Magnetic Resonance Imaging/methods , Cerebrovascular Circulation , Cerebrovascular Disorders/congenital , Equipment Design , Female , Humans , Infant, Newborn , Injections, Intravenous/instrumentation , Male , Prospective Studies
2.
J Magn Reson Imaging ; 28(4): 1019-25, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18821602

ABSTRACT

PURPOSE: To determine whether an early magnetic resonance imaging (MRI) study using perfusion-weighted imaging (PWI) may define the pattern of brain injury in term neonatal hypoxic-ischemic (HI) encephalopathy. MATERIALS AND METHODS: Five newborns with HI encephalopathy or a marker of perinatal depression, and 2 controls underwent an early MRI (at 2 to 4 days), including PWI. Relative cerebral blood flow (rCBF) values were measured. RESULTS: On early (

Subject(s)
Hypoxia-Ischemia, Brain/diagnosis , Magnetic Resonance Angiography/methods , Case-Control Studies , Cerebrovascular Circulation , Contrast Media , Female , Gadolinium DTPA , Humans , Hypoxia-Ischemia, Brain/pathology , Infant, Newborn , Male , Prospective Studies
3.
J Magn Reson Imaging ; 27(6): 1229-34, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18504740

ABSTRACT

PURPOSE: To illustrate the evolution of brain perfusion-weighted magnetic resonance imaging (PWI-MRI) in severe neonatal hypoxic-ischemic (HI) encephalopathy, and its possible relation to further neurodevelopmental outcome. MATERIALS AND METHODS: Two term neonates with HI encephalopathy underwent an early and a late MRI, including PWI. They were followed until eight months of age. A total of three "normal controls" were also included. Perfusion maps were obtained, and relative cerebral blood flow (rCBF) and cerebral blood volume (rCBV) values were measured. RESULTS: Compared to normal neonates, a hyperperfusion (increased rCBF and rCBV) was present on early scans in the whole brain. On late scans, hyperperfusion persisted in cortical gray matter (normalization of rCBF and rCBV ratios in white matter and basal ganglia, but not in cortical gray matter). Diffusion-weighted imaging (DWI) was normalized, and extensive lesions became visible on T2-weighted images. Both patients displayed very abnormal outcome: Patient 2 with the more abnormal early and late hyperperfusion being the worst. CONCLUSION: PWI in HI encephalopathy did not have the same temporal evolution as DWI, and remained abnormal for more than one week after injury. This could be a marker of an ongoing mechanism underlying severe neonatal HI encephalopathy. Evolution of PWI might help to predict further neurodevelopmental outcome.


Subject(s)
Cerebral Angiography/methods , Hypoxia-Ischemia, Brain/diagnosis , Magnetic Resonance Angiography/methods , Blood Flow Velocity , Blood Volume , Brain/blood supply , Brain/physiopathology , Cerebrovascular Circulation , Contrast Media/administration & dosage , Diffusion Magnetic Resonance Imaging/methods , Echo-Planar Imaging/methods , Female , Follow-Up Studies , Gadolinium DTPA , Humans , Hypoxia-Ischemia, Brain/physiopathology , Image Enhancement/methods , Image Processing, Computer-Assisted/methods , Infant , Infant, Newborn , Male , Severity of Illness Index , Time Factors
4.
Eur J Pediatr ; 166(5): 473-83, 2007 May.
Article in English | MEDLINE | ID: mdl-17043844

ABSTRACT

This study's aim was to assess neurodevelopmental and growth outcome until the age of 4 years of premature infants placed on early nCPAP, in the setting of the neonatal intensive care unit (NICU) and follow-up program of the Division of Neonatology of the Department of Pediatrics of the University Hospital, Lausanne, Switzerland. All consecutive inborn infants weighing <1500 g or <32 weeks of gestational age admitted to the NICU during two periods of 12 months-7.1996-6.1997 and 7.1998-6.1999-were compared before and after the systematic application of early nCPAP. Of 172 infants admitted to the NICU, 150 (87%) survived. 126 (84%) were tested at 6 months' corrected age, 121 (81%) at 18 months' corrected age, and 117 (78%) at the age of 4 years. Detailed perinatal data were collected. Follow-up included neurological examination, developmental testing and measurement of growth parameters. Statistical analyses were performed. Early application of nCPAP and avoidance of mechanical ventilation showed no adverse effects on neurodevelopment and growth. A significantly higher developmental quotient was found in the nCPAP group at 18 months' corrected age. Several trends were also noted in the nCPAP group with a decrease of intraventricular hemorrhage and in "abnormal neurodevelopment" at 6 months corrected age, a bigger head circumference at all different tested ages and a greater height at 6 and 18 months corrected ages. In conclusion, our study of developmental outcome documents the absence of any harmful effect of early application of nCPAP to treat respiratory failure in very low birthweight infants.


Subject(s)
Continuous Positive Airway Pressure/methods , Infant, Premature , Respiratory Distress Syndrome, Newborn/therapy , Administration, Intranasal , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Statistics, Nonparametric , Treatment Outcome
5.
Pediatrics ; 118(1): e107-14, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16818525

ABSTRACT

OBJECTIVE: With the increased survival of very preterm infants, there is a growing concern for their developmental and socioemotional outcomes. The quality of the early mother-infant relationship has been noted as 1 of the factors that may exacerbate or soften the potentially adverse impact of preterm birth, particularly concerning the infant's later competencies and development. The first purpose of the study was to identify at 6 months of corrected age whether there were specific dyadic mother-infant patterns of interaction in preterm as compared with term mother-infant dyads. The second purpose was to examine the potential impact of these dyadic patterns on the infant's behavioral and developmental outcomes at 18 months of corrected age. METHODS: During a 12-month period (January-December 1998), all preterm infants who were <34 weeks of gestational age and hospitalized at the NICU of the Lausanne University Hospital were considered for inclusion in this longitudinal prospective follow-up study. Control healthy term infants were recruited during the same period from the maternity ward of our hospital. Mother-infant dyads with preterm infants (n = 47) and term infants (n = 25) were assessed at 6 months of corrected age during a mother-infant play interaction and coded according to the Care Index. This instrument evaluates the mother's interactional behavior according to 3 scales (sensitivity, control, and unresponsiveness) and the child's interactional behavior according to 4 scales (cooperation, compliance, difficult, and passivity). At 18 months, behavioral outcomes of the children were assessed on the basis of a semistructured interview of the mother, the Symptom Check List. The Symptom Check List explores 4 groups of behavioral symptoms: sleeping problems, eating problems, psychosomatic symptoms, and behavioral and emotional disorders. At the same age, developmental outcomes were evaluated using the Griffiths Developmental Scales. Five areas were evaluated: locomotor, personal-social, hearing and speech, eye-hand coordination, and performance. RESULTS: Among the possible dyadic patterns of interaction, 2 patterns emerge recurrently in mother-infant preterm dyads: a "cooperative pattern" with a sensitive mother and a cooperative-responsive infant (28%) and a "controlling pattern" with a controlling mother and a compulsive-compliant infant (28%). The remaining 44% form a heterogeneous group that gathers all of the other preterm dyads and is composed of 1 sensitive mother-passive infant; 10 controlling mothers with a cooperative, difficult, or passive infant; and 10 unresponsive mothers with a cooperative, difficult, or passive infant. Among the term control subjects, 68% of the dyads are categorized as cooperative pattern dyads, 12% as controlling pattern dyads, and the 20% remaining as heterogeneous dyads. At 18 months, preterm infants of cooperative pattern dyads have similar outcomes as the term control infants. Preterm infants of controlling pattern dyads have significantly fewer positive outcomes as compared with preterm infants of cooperative pattern dyads, as well as compared with term control infants. They display significantly more behavioral symptoms than term infants, including more eating problems than term infants as well as infants from cooperative preterm dyads. Infants of the controlling preterm dyads do not differ significantly for the total development quotient but have worse personal-social development than term infants and worse hearing-speech development than infants from cooperative preterm dyads. The preterm infants of the heterogeneous group have outcomes that can be considered as intermediate with no significant differences compared with preterm infants from the cooperative pattern or the controlling pattern dyads. CONCLUSION: Among mother-preterm infant dyads, we identified 2 specific patterns of interaction that could play either a protective (cooperative pattern) or a risk-precipitating (controlling pattern) role on developmental and behavioral outcome, independent of perinatal risk factors and of the family's socioeconomic background. The controlling pattern is much more prevalent among preterm than term dyads and is related to a less favorable infant outcome. However, the cooperative pattern still represents almost 30% of the preterm dyads, with infants' outcome comparable to the ones of term infants. These results point out the impact of the quality of mother-infant relationship on the infant's outcome. The most important clinical implication should be to support a healthy parent-infant relationship already in the NICU but also in the first months of the infant's life. Early individualized family-based interventions during neonatal hospitalization and transition to home have been shown to reduce maternal stress and depression and increase maternal self-esteem and to improve positive early parent-preterm infant interactions.


Subject(s)
Child Development , Infant Behavior , Infant, Premature/psychology , Mother-Child Relations , Mothers/psychology , Female , Follow-Up Studies , Humans , Infant , Infant, Newborn , Prospective Studies
6.
Antimicrob Agents Chemother ; 50(7): 2563-8, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16801447

ABSTRACT

Plasma imipenem concentrations were measured in 19 critically ill children (median age, 0.8 year; range, 0.02 to 12.9 years). Wide interindividual variations (2 to 4x at peak and >10x at trough concentrations) resulted in unpredictable plasma levels in several children. To avoid subtherapeutic drug levels, we recommend treatment with at least 100 mg/kg of body weight/day of imipenem-cilastatin for critically ill children requiring such therapy.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Bacterial Infections/drug therapy , Critical Illness , Cross Infection/drug therapy , Imipenem/pharmacokinetics , Area Under Curve , Bacterial Infections/microbiology , Child , Child, Preschool , Cilastatin/administration & dosage , Cilastatin, Imipenem Drug Combination , Cross Infection/microbiology , Drug Combinations , Drug Therapy, Combination , Female , Humans , Imipenem/administration & dosage , Infant , Infant, Newborn , Infusions, Intravenous , Male
7.
Am J Physiol Heart Circ Physiol ; 282(1): H273-80, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11748072

ABSTRACT

Atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) are important dilators of the pulmonary circulation during the perinatal period. We compared the responses of pulmonary arteries (PA) and veins (PV) of newborn lambs to these peptides. ANP caused a greater relaxation of PA than of PV, and CNP caused a greater relaxation of PV than of PA. RIA showed that ANP induced a greater increase in cGMP content of PA than CNP. In PV, ANP and CNP caused a similar moderate increase in cGMP content. Receptor binding study showed more specific binding sites for ANP than for CNP in PA and more for CNP than for ANP in PV. Relative quantitative RT-PCR for natriuretic peptide receptor A (NPR-A) and B (NPR-B) mRNAs show that, in PA, NPR-A mRNA is more prevalent than NPR-B mRNA, whereas, in PV, NPR-B mRNA is more prevalent than NPR-A mRNA. In conclusion, in the pulmonary circulation, arteries are the major site of action for ANP, and veins are the major site for CNP. Furthermore, the differences in receptor abundance and the involvement of a cGMP-independent mechanism may contribute to the heterogeneous effects of the natriuretic peptides in PA and PV of newborn lambs.


Subject(s)
Animals, Newborn/physiology , Atrial Natriuretic Factor/pharmacology , Gene Expression Regulation/physiology , Guanylate Cyclase/genetics , Muscle, Smooth, Vascular/physiology , Natriuretic Peptide, C-Type/pharmacology , Pulmonary Artery/physiology , Pulmonary Veins/physiology , Receptors, Atrial Natriuretic Factor/genetics , 1-Methyl-3-isobutylxanthine/pharmacology , Animals , Cyclic GMP/metabolism , Gene Expression Regulation/drug effects , In Vitro Techniques , Muscle Relaxation/drug effects , Muscle, Smooth, Vascular/drug effects , Nitric Oxide/pharmacology , Oxadiazoles/pharmacology , Pulmonary Artery/drug effects , Pulmonary Veins/drug effects , Quinoxalines/pharmacology , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Sheep , Transcription, Genetic/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...